18
April 2024 Apr 2024
The ALIGNED study may help your patients with depression find the right antidepressant medication.
The George Institute for Global Health, St Vincent’s Hospital Sydney, and collaborating institutions across Australia are seeking participants for a new study looking at whether tailored antidepressant therapy based on individual patient’s genetic makeup can improve remission rates in depressed patients initiating antidepressants by reducing trial-and-error iterations, and better managing side effects.
The ALIGNED study is an investigator-initiated, double-blind randomised-controlled trial of pharmacogenomics-guided therapy versus standard care for people with depression. The study is funded by the Medical Research Future Fund.
For all participants enrolled in the study, the prescribing clinician will be provided with an individualised treatment guide containing antidepressant recommendations to inform choice/dosing of antidepressant therapy for your patient.
Click here to find out more about the study. GP Practice flyer. Introductory letter.
Subscribe to our mailing list to get all the latest news updates delivered to your inbox.
Emerging research has highlighted a relationship between diet and genetics, suggesting that individuals may benefit more from personalised dietary recommendations based on their genetics.
Aged care is currently experiencing immense change based on the recommendations of the Royal Commission into Aged Care Quality and Safety. Much of this change is being led by the Australian Government and by aged care providers. As researchers, we want to understand how we can best support this change. We want to know what you think are most critical areas to research in residential aged care.
Bacterial skin infections, especially impetigo, are rising concerns in Australia, with one in four Australians affected. The Faculty of Health at the University of Canberra is delving into treatment strategies, revealing gaps in effective treatments.